GlassScriptPhysician profile
Lindsay Pattison
NPI 1174818009
$2,833.60
in general payments reported to CMS, 2019-2025
48 companies · $578 in 2025
The $578 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $594 · 2020: $235 · 2021: $246 · 2022: $253 · 2023: $324 · 2024: $604 · 2025: $578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,505.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $372.23 | 2019-2023 | Tysabri, Vumerity |
| Jazz Pharmaceuticals INC. | $238.81 | 2021-2025 | |
| Amneal Pharmaceuticals LLC | $169.01 | 2020-2025 | Crexont, Rytary |
| Supernus Pharmaceuticals, INC. | $165.40 | 2019-2020 | |
| Ucb, INC. | $147.36 | 2019-2025 | Briviact, Zilbrysq, Fintepla |
| E.R. Squibb & Sons, L.L.C. | $116.75 | 2024 | Zeposia |
| Lilly USA, LLC | $108.66 | 2019-2025 | Kisunla, Emgality |
| Amgen INC. | $100.07 | 2020-2021 | |
| Abbvie INC. | $97.43 | 2021-2025 | |
| Vanda Pharmaceuticals INC. | $93.34 | 2024 | Ponvory |
| Novartis Pharmaceuticals Corporation | $84.28 | 2019-2025 | |
| Tg Therapeutics, INC. | $81.58 | 2024-2025 | |
| Genentech USA, INC. | $76.29 | 2019-2025 | Ocrevus Zunovo |
| Sunovion Pharmaceuticals INC. | $71.82 | 2019 | |
| Argenx US, INC. | $70.40 | 2025 | Vyvgart, Vyvgart Hytrulo |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsay Pattison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.